Association of Body Mass Index With Decline in Residual Kidney Function After Initiation of Dialysis

American Journal of Kidney Diseases

Volumn 53, Issue 6, 2009, Pages 1014-1023

  Drechsler, Christiane ^a   de Mutsert, Renée ^a   Grootendorst, Diana C ^a   Boeschoten, Elisabeth W ^b   Krediet, Raymond T ^c   le Cessie, Saskia ^a   Wanner, Christoph ^d   Dekker, Friedo W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hans Mak Institute   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

body mass index; cohort study; dialysis; glomerular filtration rate; kidney function; Obesity

Indexed keywords

NITROGEN;

ADULT; ANURIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIALYSIS; DIURESIS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEINURIA; RISK ASSESSMENT; SMOKING;

ADULT; AGED; BODY MASS INDEX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS;

EID: 65549144928     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.11.027     Document Type: Article

References (54)

1. Bargman J.M., Thorpe K.E., and Churchill D.N. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA Study. J Am Soc Nephrol 12 (2001) 2158-2162
2. Maiorca R., Brunori G., Zubani R., et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 10 (1995) 2295-2305
3. Rocco M., Soucie J.M., Pastan S., and McClellan W.M. Peritoneal dialysis adequacy and risk of death. Kidney Int 58 (2000) 446-457
4. Shemin D., Bostom A.G., Laliberty P., and Dworkin L.D. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38 (2001) 85-90
5. Termorshuizen F., Korevaar J.C., Dekker F.W., van Manen J.G., Boeschoten E.W., and Krediet R.T. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 41 (2003) 1293-1302
6. Termorshuizen F., Dekker F.W., van Manen J.G., Korevaar J.C., Boeschoten E.W., and Krediet R.T. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15 (2004) 1061-1070
7. Ejerblad E., Fored C.M., Lindblad P., Fryzek J., McLaughlin J.K., and Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol 17 (2006) 1695-1702
8. Foster M.C., Hwang S.J., Larson M.G., et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis 52 (2008) 39-48
9. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
10. Gelber R.P., Kurth T., Kausz A.T., et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46 (2005) 871-880
11. Hallan S., de Mutsert R., Carlsen S., Dekker F.W., Aasarod K., and Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: Are men more vulnerable?. Am J Kidney Dis 47 (2006) 396-405
12. Elsayed E.F., Sarnak M.J., Tighiouart H., et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52 (2008) 29-38
13. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
14. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., and Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 (2004) 1870-1876
15. Chagnac A., Weinstein T., Korzets A., Ramadan E., Hirsch J., and Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278 (2000) F817-F822
16. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., and Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14 (2003) 1480-1486
17. D'Agati V.D., and Markowitz G.S. Supersized kidneys: Lessons from the preclinical obese kidney. Kidney Int 73 (2008) 909-910
18. Kambham N., Markowitz G.S., Valeri A.M., Lin J., and D'Agati V.D. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59 (2001) 1498-1509
19. de Mutsert R., Snijder M.B., van der S.-d.B., et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 18 (2007) 967-974
20. Dwyer J.T., Larive B., Leung J., et al. Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?. Kidney Int 68 (2005) 1766-1776
21. Pifer T.B., McCullough K.P., Port F.K., et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 62 (2002) 2238-2245
22. Snyder J.J., Foley R.N., Gilbertson D.T., Vonesh E.F., and Collins A.J. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64 (2003) 1838-1844
23. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73 (2008) 391-398
24. Kalantar-Zadeh K., Ikizler T.A., Block G., Avram M.M., and Kopple J.D. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 42 (2003) 864-881
25. Kalantar-Zadeh K., and Balakrishnan V.S. The kidney disease wasting: Inflammation, oxidative stress, and diet-gene interaction. Hemodial Int 10 (2006) 315-325
26. Garg A.X., Blake P.G., Clark W.F., Clase C.M., Haynes R.B., and Moist L.M. Association between renal insufficiency and malnutrition in older adults: Results from the NHANES III. Kidney Int 60 (2001) 1867-1874
27. Kopple J.D., Greene T., Chumlea W.C., et al. Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD Study. Kidney Int 57 (2000) 1688-1703
28. ERA-EDTA Registry: ERA-EDTA Registry 2006 Annual Report (2008), Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands 126 Appendix 1-Grouping of primary renal diseases
29. Khan I.H., Catto G.R., Edward N., Fleming L.W., Henderson I.S., and MacLeod A.M. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 341 (1993) 415-418
30. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation (1999), World Health Organization, Geneva, Switzerland
31. Jansen M.A., Hart A.A., Korevaar J.C., Dekker F.W., Boeschoten E.W., and Krediet R.T. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62 (2002) 1046-1053
32. Moist L.M., Port F.K., Orzol S.M., et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11 (2000) 556-564
33. Singhal M.K., Bhaskaran S., Vidgen E., Bargman J.M., Vas S.I., and Oreopoulos D.G. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 20 (2000) 429-438
34. Brown S.C., and O'Reilly P.H. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: Evidence for a new gold standard. J Urol 146 (1991) 675-679
35. Gaspari F., Perico N., and Remuzzi G. Measurement of glomerular filtration rate. Kidney Int Suppl 63 (1997) S151-S154
36. Gaspari F., Perico N., Matalone M., et al. Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol 9 (1998) 310-313
37. Holliday M.A., Heilbron D., al Uzri A., et al. Serial measurements of GFR in infants using the continuous iothalamate infusion technique. Southwest Pediatric Nephrology Study Group (SPNSG). Kidney Int 43 (1993) 893-898
38. Rahn K.H., Heidenreich S., and Bruckner D. How to assess glomerular function and damage in humans. J Hypertens 17 (1999) 309-317
39. National Kidney Foundation. KDOQI: Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am J Kidney Dis 48 (2006) S1-S322 (suppl 1)
40. Dombros N., Dratwa M., Feriani M., et al. European Best Practice Guidelines for peritoneal dialysis. 2 The initiation of dialysis. Nephrol Dial Transplant 20 (2005) ix3-ix7 (suppl 9)
41. European Best Practice Guidelines Expert Group on Hemodialysis ERA: Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant 17 (2002) S7-S15 (suppl 7)
42. Rosenberg D.E., Jabbour S.A., and Goldstein B.J. Insulin resistance, diabetes and cardiovascular risk: Approaches to treatment. Diabetes Obes Metab 7 (2005) 642-653
43. Aneja A., El Atat F., McFarlane S.I., and Sowers J.R. Hypertension and obesity. Recent Prog Horm Res 59 (2004) 169-205
44. Hunsicker L.G., Adler S., Caggiula A., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51 (1997) 1908-1919
45. Serra A., Romero R., Lopez D., et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 73 (2008) 947-955
46. Ritz E. Obesity and CKD: How to assess the risk?. Am J Kidney Dis 52 (2008) 1-6
47. Chen H.M., Li S.J., Chen H.P., Wang Q.W., Li L.S., and Liu Z.H. Obesity-related glomerulopathy in China: A case series of 90 patients. Am J Kidney Dis 52 (2008) 58-65
48. Bosma R.J., Krikken J.A., Homan van der Heide J.J., de Jong P.E., and Navis G.J. Obesity and renal hemodynamics. Contrib Nephrol 151 (2006) 184-202
49. de Jong P.E., Verhave J.C., Pinto-Sietsma S.J., and Hillege H.L. Obesity and target organ damage: The kidney. Int J Obes Relat Metab Disord 26 (2002) S21-S24 (suppl 4)
50. Lastra G., Manrique C., and Sowers J.R. Obesity, cardiometabolic syndrome, and chronic kidney disease: The weight of the evidence. Adv Chronic Kidney Dis 13 (2006) 365-373
51. Tomaszewski M., Charchar F.J., Maric C., et al. Glomerular hyperfiltration: A new marker of metabolic risk. Kidney Int 71 (2007) 816-821
52. Wolf G., Chen S., Han D.C., and Ziyadeh F.N. Leptin and renal disease. Am J Kidney Dis 39 (2002) 1-11
53. Hall J.E., Crook E.D., Jones D.W., Wofford M.R., and Dubbert P.M. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci 324 (2002) 127-137
54. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47